Table 2.
Lung region | Groups | Atelectasis | Necrosis | Edema | Alveolar inflammation | Interstitial inflammation | Alveolar hemorrhage | Interstitial hemorrhage | Total |
---|---|---|---|---|---|---|---|---|---|
UPPER | INSURE | 0.17 ± 0.41 | 0 | 0 | 0.17 ± 0.41 | 0.67 ± 0.52 | 0 | 0.17 ± 0.41 | 1.17 ± 1.17 |
LISA‐NT | 0.17 ± 0.41 | 0 | 0 | 0.50 ± 0.54 | 1.16 ± 1.16 | 0 | 0 | 1.83 ± 1.17 | |
LISAcath | 1.00 ± 1.10 | 0 | 0 | 0.83 ± 0.54* | 1.33 ± 0.81 | 0 | 0 | 3.16 ± 2.04 | |
MIDDLE | INSURE | 0.33 ± 0.51 | 0 | 0 | 0.33 ± 0.51 | 1.00 ± 0.89 | 0 | 0 | 1.67 ± 1.51 |
LISA‐NT | 0.83 ± 0.75 | 0 | 0.17 ± 0.40 | 0.33 ± 0.51 | 1.33 ± 1.03 | 0 | 0 | 2.67 ± 1.75 | |
LISAcath | 0.83 ± 1.69 | 0 | 0 | 0.83 ± 0.40 | 1.33 ± 1.03 | 0 | 0 | 3.00 ± 2.19 | |
LOWER | INSURE | 0.33 ± 0.52 | 0 | 0 | 0.33 ± 0.52 | 1.00 ± 0.89 | 0.17 ± 0.41 | 0 | 1.83 ± 1.47 |
LISA‐NT | 0.66 ± 0.81 | 0 | 0 | 0.33 ± 0.52 | 0.83 ± 0.75 | 0 | 0 | 1.83 ± 1.72 | |
LISAcath | 1.33 ± 1.02 | 0 | 0.17 ± 0.40 | 1.33 ± 0.52*$ | 1.50 ± 0.83 | 0 | 0.50 ± 0.54 | 3.70 ± 2.50*$ | |
TOTAL | INSURE | 0.28 ± 0.46 | 0 | 0 | 0.28 ± 0.46 | 0.89 ± 0.76 | 0.06 ± 0.24 | 0.06 ± 0.24 | 1.56 ± 1.34 |
LISA‐NT | 0.56 ± 0.70 | 0 | 0.05 ± 0.23 | 0.38 ± 0.50 | 1.11 ± 0.96 | 0 | 0 | 2.10 ± 1.53 | |
LISAcath | 1.00 ± 1.00* | 0 | 0.05 ± 0.23 | 1.00 ± 0.48*$ | 1.38 ± 0.85 | 0 | 0.16 ± 0.38 | 3.6 ± 2.25*$ |
Statistical differences were assessed using Wilcoxon non‐parametric test; (*)P < 0.05 versus Insure group, ($)P < 0.05 versus LISA‐NT group. Values are expressed as mean ± SD.